WOW JUST WOW: Just One Single CyberKnife Session May Be All That’s Needed to Treat Prostate Cancer. Early study results look very promising.
Accuray, the manufacturer of CyberKnife introduced this novel strategy for prostate cancer treatment, unveiling the so called, PRO-FAST protocol at the European Society for Radiotherapy and Oncology meeting in Milan. #ESTRO26
Dr. Andre Fodor from the San Raffaele Scientific Institute #IRCCS shared clinical insights on the PRO-FAST method, which aims to significantly reduce the treatment timeline for eligible patients.
Here’s a link to listen to Dr. Foder:
The initiative underscores the growing trend towards accelerated cancer therapies for patients using advanced radiotherapy technologies.
To date 37 prostate cancer patients have been treated. Toxicity levels were low, and the one year follow up shows very well controlled PSA levels.
Researchers are only half way through the study but believe the PRO-FAST treatment is feasible in the not too distant future.
Currently 5 CyberKnife sessions are used to treat prostate cancer, compared to 42 treatment sessions with other types of radiation therapy.
The approach utilizing single-day, single-fraction radiotherapy delivered through the CyberKnife system would be much more convienent for prostate cancer patients, greatly reducing the stress and time it takes to complete cancer treatment.